Supernus Pharmaceuticals Inc (SUPN)
35.82
-0.30
(-0.83%)
USD |
NASDAQ |
Nov 21, 16:00
35.81
-0.01
(-0.03%)
After-Hours: 20:00
Supernus Pharmaceuticals Gross Profit Margin (Quarterly): 89.99% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 89.99% |
| June 30, 2024 | 89.36% |
| March 31, 2024 | 88.65% |
| December 31, 2023 | 88.06% |
| September 30, 2023 | 87.26% |
| June 30, 2023 | 84.44% |
| March 31, 2023 | 84.74% |
| December 31, 2022 | 86.28% |
| September 30, 2022 | 85.41% |
| June 30, 2022 | 87.97% |
| March 31, 2022 | 88.24% |
| December 31, 2021 | 89.32% |
| September 30, 2021 | 87.82% |
| June 30, 2021 | 82.29% |
| March 31, 2021 | 88.58% |
| December 31, 2020 | 87.09% |
| September 30, 2020 | 86.21% |
| June 30, 2020 | 93.38% |
| March 31, 2020 | 95.63% |
| December 31, 2019 | 95.91% |
| September 30, 2019 | 95.28% |
| June 30, 2019 | 96.14% |
| March 31, 2019 | 95.69% |
| Date | Value |
|---|---|
| December 31, 2018 | 96.39% |
| September 30, 2018 | 95.92% |
| June 30, 2018 | 96.30% |
| March 31, 2018 | 96.38% |
| December 31, 2017 | 95.30% |
| September 30, 2017 | 94.71% |
| June 30, 2017 | 94.91% |
| March 31, 2017 | 94.88% |
| December 31, 2016 | 93.95% |
| September 30, 2016 | 93.97% |
| June 30, 2016 | 94.67% |
| March 31, 2016 | 95.40% |
| December 31, 2015 | 93.60% |
| September 30, 2015 | 94.29% |
| June 30, 2015 | 95.06% |
| March 31, 2015 | 94.37% |
| December 31, 2014 | 92.69% |
| September 30, 2014 | 94.18% |
| June 30, 2014 | 94.40% |
| March 31, 2014 | 94.56% |
| December 31, 2013 | 89.68% |
| September 30, 2013 | 97.37% |
| June 30, 2013 | 98.58% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
82.29%
Minimum
Jun 2021
95.91%
Maximum
Dec 2019
88.33%
Average
88.01%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 86.80% |
| United Therapeutics Corp | 88.90% |
| Ligand Pharmaceuticals Inc | 95.27% |
| Tonix Pharmaceuticals Holding Corp | 44.90% |
| Agios Pharmaceuticals Inc | 91.27% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 6.32% |
| Return on Assets | 4.58% |
| Return on Invested Capital | 6.32% |
| Profit Margin (Quarterly) | 21.91% |
| Operating Margin (Quarterly) | 22.67% |
| Return on Net Operating Assets | 6.34% |